Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Amortizatization of Intangibles (2021 - 2024)

Trinity Biotech's Amortizatization of Intangibles history spans 4 years, with the latest figure at $109000.0 for Q4 2024.

  • On a quarterly basis, Amortizatization of Intangibles fell 76.3% to $109000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $854338.0, a 4.01% decrease, with the full-year FY2025 number at $1.4 million, up 16.39% from a year prior.
  • Amortizatization of Intangibles hit $109000.0 in Q4 2024 for Trinity Biotech, up from $338.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for TRIB hit a ceiling of $744473.0 in Q2 2024 and a floor of $56.0 in Q3 2023.
  • Historically, Amortizatization of Intangibles has averaged $188757.5 across 4 years, with a median of $109000.0 in 2024.
  • The widest YoY moves for Amortizatization of Intangibles: up 200717.29% in 2023, down 99.98% in 2023.
  • Tracing TRIB's Amortizatization of Intangibles over 4 years: stood at $228000.0 in 2021, then fell by 5.7% to $215000.0 in 2022, then skyrocketed by 113.95% to $460000.0 in 2023, then plummeted by 76.3% to $109000.0 in 2024.
  • Business Quant data shows Amortizatization of Intangibles for TRIB at $109000.0 in Q4 2024, $338.0 in Q3 2024, and $744473.0 in Q2 2024.